/ !/"  

 
 

#  1
%&'(

1.
2.
3.

4.

5.
6.
7.
8.
9.

#*
  680312  (Pathophysiology)

,-#. 
3 -. (3-0-6)
#&
*(
"

 
#&

(
"

  
12  343 5.
6 7
8 89:-
;
1
,
12&%
2 
 *,
12&%
2&%
2 
  3.1.=> 7? =@ (E-mail: piyapong@buu.ac.th)
2&%
I.1.6 - 878J
I.--5 -

I.1.  - 7.3 1K I.1.7LK 3735.3.1.=> 7? =@
 .
M37 MS 201 38  
9  038-103166 
39 :P- 3166
" 
/4(5
 :Q?R 1  S-=TR 3

   %  
  .   (pre-requisite) 680206  7 = 7 :  J 37

-5? 8 680219 J37
-5?

 %
C
% (co-requisites) V
.


 M37 MS 38  
 
 
, -#
(
(



 
4. 5 7
2557
#  2 , .#*(
 1

1.

, .#

 

4R3Q?-S8M -6

M

Y1 7-S
1. 3
V;7-J37

.7Z P-.7J1:I1=V1M
2. 3
;7-3.7
- -J37

.7Z P-.7J1:I1=V1M
3. 3
 R
-
38177-V1M

4. 3
 : R16V=
15;7-M

5. =5
MP-Q?P- S-7
2.
(
 1H
CI/(
(

 
=
=57-S  4R3PM3
-37.3I-MJ37 8=
=57-4S3PM


 -
3.
3 8-;4R33-8


1
PM 4R3PM-JMP6V19 
YQ7

JMP6=

15P-:RI1=J37

.7Z V1M1R7JQS- 8
Y-;
MV=PM=\ 4S-@-;

;7-43Q?.331P- .3V= 
 S7 4R3.7
6 1-
3- 91-M--M1M -373.7=\- =
8.7
PMIM -M-M
M6
8.7JM3
R
#  3 !*
- 

1.

-J 
 

;7-8=

15J37

.7Z J37
-5?P-:I1= V1M8. 1

]


= 

M
-4S3 

 P631431 

P6 

71-3 

71=^ 

.3
VM.384
-5 91-M-

-P-;7-.
-J37

.7Z P:I1= 
YQ7;7-RI1=J37

.7Z R
-

37-
Function and homeostasis mechanisms of various organ systems in pathological states,
including cell abnormalities, neuro-muscular, cardiovascular, respiratory, gastrointestinal, renal,
endocrine and reproductive systems. Emphasized integrative compensation of associated
systems in pathological state. Clinical signs and symptoms related to organ malfunction.
2.

,-KH%." 










LM(N  /
" /
LM


 %


45  R9
7

6

M37J37-

V
.


6  R9
7/ =1

3.
,-K.( #1,
1H#% -(
**- 
*.(O

 
-
YJ3;=Q?8;8--;636IM=-7- 836IM3V1M- 1  R9
7.3 =1

#  4 
CI2


&%

1.

2.

 J

 ,
J


!
1.1 !J

 ,
J

%CI
-

]4R3 56


-  7.3 M
-


I13
.3-37  7
8R781M3

-
5
6
P-1;7 P-78
1.2  J
,H%CI


&% K -# H#%   
91;-1PM-
- JM    -7 M 
JM    - - 5 - 8]h - 4R 3 JM    -5  S 7 P:=i

- JM-V
.-M3. 80% J37 S7
16Q76
K3

- J1- M37.7P


36IM=-7-
-

]4R3 P-3

- 8.7PMY

J37
 6Q76JM-V1M
-  k

Jl^7
 .-  S7P6- 8V
. 15.7=\-M1.3  J
(
 2
- =
 - 6 L 
JM    -   - 3
8. 7 7-R V 1M 

3


;-1
- YMJM-- 5 -
. 5  S7 6 1KJM3


&%
2.1 
&%,%' %

-

M 4S-@-7  4R3-;V==5P-
-

MRmP-  4R3-;
MRV1MV==3
3 V1M3.7YM378



- 
YM-M 4R3-MV1M1M-3731
2.2  J


 M3
 3.7=3
1M=: 1 - 43 3.7 =>1
93PM-V1M] Y
JM3 7 R

- noPM-6
=1h-R; mRV1M6
l^7433.- noPM-V1M S7;Y
R
4R37R- M3
8--; web site  4R3PM-
Q?M-M1M-37-3 S-2.3  J
(
 2

3.

4.

5.

3
 S-Z  7
 4R3IM3-6V1M
.IM-1
-4S3V1M 43V
. 7-R
3

 
YQ73
7:8=:
(PQQ
3.1 (PQQ%CI
- 
Y 8 7JM3
V1M3.7


91PM  
M8

8-1R-

- 
Y8M=^m1M
-7V1M3.7YM378


3.2  J

- 6 1-3-:=i
PM31M37
:
 8
6 1PM

3: =I137 ; PM -  V1M  1    JM 3
  6I137 4R 3 -; V=. 
3
I137RV1M
-
3

PM;7-83
; Y
 4R3 5M -PM
M-M R

6
internet 438.7JM3
34R-Z
3.3  J
(
 2
- 3
7: 3
=: 813
.3 7- =
-6I1378JM3
R-;-3
- =
- L
J37-P-;7-RV1M

3


 CJ1
#. * 
2 
4.1  CJ1
#. * 
2 %CI
- 
Y=
  ;7-.

IM34R- S7P-@-IM-;8IM.
7-


I13
8- .3-MRRV1M

3


-

-5?
-R1
IM.
7-P-378
5 RV=
-

 K83


8.77
1J37IM34R-
63
4.2  J

- ;-1PM;7-=\-5.
.3
4.3  J
(
 2
- =
-67-R
3

PM;
- 3
Y
L
;7-6 4R3-.
5.


 
#1 


*
H% KK

5.1 
 
#1  

 
*
H% KK 
% 
CI
- 
YPM  9-9  -P-4
M - h


8-;  -3JM 3
 
316-1.34R3V1M

- 
Y 8=
I91PM
M787Y

5.2  J

-
3

Q?  4R3PMnoJM3
=R-8=77 8

Y4
M-JM3
 R

68.7JM3

5.3  J
(
 2
- =
-67-R
3

PM;  ?-;-391PM9-9-JM

. 8
YM37

J37JM3

#  5 *2
*
(
 2
1.

*2

6 13-
 3  R9
7/ =1 -5 - L 
1  13.00 - 15.50 -. M37 MS

( #1
(/ /()

,-
K

1
(14 .. 57)

2
(21 .. 57)

3
(28 .. 57)

1
2

4
(4 .. 57)

5
(11 .. 57)

1
2

4#
Unit 1: Disorders of endocrine function (7)
- Pituitary and growth disorders
- Thyroid disorder
- Disorders of adrenal function
- Diabetes mellitus & metabolic syndrome
Case study: Diabetes mellitus & metabolic
syndrome
Unit 2: Disorders of reproductive function
(2)
- Menstrual disorder
- Infertility
- Gestational disorder
Case study: Menstrual disorder
Unit 3: Disorders of renal function (4)
- Disorders of glomerular function
- Tubulointestinal disorders
- Renal failure
Case study: Renal failure
Unit 4: Alterations in fluids & electrolytes (2)
- Alterations in fluid volume
- Alterations in sodium, potassium & calcium
balance

,





*H %
1. 863=3

 3 - 8 . -   P M V = 3.  .7-M
2.
1M power point
slide 81 -
3. PM-5==1h-R
V1M
4. PM;Y
R-M-1J S7
5. PM- S7;Y
817

1h6. 13
 S- 1 -

2&%
--5

--5

--5
--5

--5

--5
=> 7?

Case study: Fluids & electrolytes imbalance

6
(18 .. 57)

7
(25 .. 57)

8-9
(29 .. - 10
. . 57)
10
(16 .. 57)

6 -

Unit 5:Disorders of cell growth & function (3)

- Cellular adaptation, cell injury & dead
- Necrosis & apoptosis
- Inflammatory response
- Tissue repair and wound healing
Case study: Inflammatory disease
Unit 6:Disorders of neuromuscular function
(8)
- Upper motor neuron diseases
- Lower motor neuron diseases
- Cerebellar lesions
Case study: Cerebrovascular diseases and
Myasthenia gravis

=> 7?

" : Unit 1 - 5

3

11
(23 .. 57)
* -=>

 - 1
3-1*

12
(30 ..57 )

13
(6 .. 57)

- Basal ganglia lesions

Case study: Parkinson)disease
- Disorder of sensory system
- Spinal cord injury
- Mechanisms of pain
Case study: Migraine headache
- Degenerative disorders
- Brain dysfunction
- Seizure disorders
Case study: Alzheimer)s disease
Unit 7: Disorders of gastrointestinal function
(4)
- Disorders of motility
- Disorders of secretion
- Disorders of digestion and absorption
- Disorders of hepatobiliary function
Case study: Gastroesophageal reflux disease
Unit 8: Blood disorders (4)
- Red blood cell disorders
- White blood cell disorders

!,
1

1. 863=3
 6 -
 3 - 8 . -   P M V = 3.  .7-M
2.
1M power point
slide 81 -
3. PM-5==1h-R
V1M
6 -
4. PM;Y
R-M-1J S7
5. PM- S7;Y
817

1h6 -
13
 S- .61 -
6 -

  -

14
(13 .. 57)

1
2

15
(20 .. 57)
16
(27 .. 57)

3
2
1

17
(4 .. 57)

18 - 19
(8 - 19 J. .
57)

2.

  -

- Disorders of hemostasis
Case study: Blood disorders
Unit 9: Disorders of cardiovascular function
(7)
- Disorders of cardiac function
- Disorders of blood pressure regulation
- Disorders of blood flow in systemic circulation
- Heart failure
- Circulatory shock
- Case study: Heart failure
Unit 10: Disorders of respiratory function
(4)
- Disorders of lung inflation
- Obstructive airway disorders
- Pulmonary vascular disorders
- Obstructive airway disorders
- Pulmonary vascular disorders
- Pulmonary edema and respiratory failure
Case study: Lung diseases

  -
  -
7LK

7LK

(" : Unit 6 - 10

!,
1

*2
(
 2


&%
2


&%
#  4
JM3 1, 3
JM3 1, 2, 3
JM3 1, 2, 3

 J
(
 
JM S--8 L
P- S13
 S-Z 1 -
3
 S7R 1
3
 S7R 2

( #1(
 

 .


(
 

5 =1

5 =1
9-10
18-19

40.0%
60.0%

#  6 
C
(




6.1 -
*
#
1) --5 -
3=3

4R37 

.3
VM.3


4
-5 8 

J
Y.=^

2) 6 - 878J 3=3

4R37 J37] 


= 8 

71-3
3)   - 7.3 1K 3=3

4R37 

431 8


 P631431
4) 7LK 3735.- 3=3

4R37 

P6
5) => 7? =@ 3=3

4R37 

= 8

I1=J37
- ?
15-S; 438. 811.7
6.2 
*
%&- Q V
.

6.3 
*
%&*-
1) McPhee SJ., Lingappa VR., & Ganong WF. Pathophysiology of Disease: An
Introduction to Clinical Medicine. 6th ed., McGraw-Hill, NewYork, 2010.
2) Porth CM. Pathophysiology : Concepts of Altered Health States. 8th ed., Lippincott
Williams & Wilkins, Philadelphia, 2010.
3) Silbernagl S., Lang F. Color Atlas of Pathophysiology. 2nd ed., Thieme, NewYork, 2000.
4) Curtis L. Atlas of Pathophysiology. 3rd ed., Lippincott Williams & Wilkins, NewYork,
2009.
. Website .H,-#

 % %C  
1) Free MIT Open Course Ware: http://ocw.mit.edu/index.htm
2) E-learning J37
 
 : http://ncourse.buu.ac.th
3) Free data base of medicine: http://accessmedicine.com/features.aspx
#  7 
(
 *(
(

- 


 
7.1 J1
(
 (
 J 2

 K 
- 8

=
-IM3-88

=
-
7.2 J1
(
 

- =
-68--3
81J37- 7-37.3 
(
(


- 6=^mR1JQS-.7-3- 
YQ7JM3  ?J37-68

=
-  4R3-;
=\-8-7P-=
=578 --3- -;I3
I=
-
=
=57-3-  4R3PM - Q?
5 Y5=7R S7VM
7.4 

\2]J ^
 

- 6JM33
.=\-V=
8I-3- 8I 7JM33

- =5
5.
  4R3 6 11.
- 8-;-3I 11.3

=5
6J37 4R3 6P-;1
.3V=

7.5 
- 
*
*2(
(
(
 J 2


 
- -;JM3
6=
-5=I-3-
PMP- 678I-=
=578

-P-5Z 4 =T 
8I-=
=57 


2
% (Test Blueprint)


1. Unit 1: Disorders of
endocrine function
2. Unit 2: Disorders of
reproductive function
3. Unit 3: Disorders of renal
function
4. Unit 4: Alterations in
fluids and electrolytes
5. Unit 5: Disorders of cell
growth and function
6. Unit 6: Disorders of
neuromuscular function
7. Unit 7: Disorders of
respiratory function
8. Unit 8: Blood disorders
9. Unit 9: Disorders of
cardiovascular function
10. Unit 10: Disorders of
gastrointestinal function

6;--JM3
(O
%

&%-,-


%H,

10

2
5
2
4
7

3
8
3
6
12

-'(H%  
#1
12
5
4

,-
%
35

4.44

10

8.88

20

4.44

10

6.66

15

17.7

40

8.88

20

6.66
17.7

3
8

15
40

8.88

20

100

45

225

0
3

5
5
15

6
4

8
5

2
2

12

14

6
70
30

,- 
7

4
4

5
51
20

%
15.5

8
81
40

1
23
10